Importance of penicillinase production for activity of penicillin alone or in combination with sulbactam in experimental endocarditis due to methicillin-resistant Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 5, 1996, Pages 1219-1224

  Fantin, Bruno ^a   Pierre, Josiane ^b   Castéla Papin, Nathalie ^a   Saint Julien, Line ^a   Drugeon, Henri ^c   Farinotti, Robert ^a   Carbon, Claude ^a  

^a BICHAT HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c CHU de Nantes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN G; PENICILLINASE; SULBACTAM; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENTIATION; ENDOCARDITIS; FEMALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; RABBIT;

EID: 0029965514     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.5.1219     Document Type: Article

References (31)

1. Bonner, W. M., and R. A. Laskey. 1974. A film detection method for tritiumlabelled proteins and nucleic acids in polyacrylamide gels Eur J. Biochem. 46:83-88.
2. Cantoni, L., A. Wenger, M. P. Glauser, and J. Bille. 1989. Comparative efficacy of amoxicillin-elavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats. J. Infect. Dis 159:989-993
3. Caron, F., L. Gutmann, A. Bure, B. Pangon, J.-M. Vallois, A. Pechinot, and C. Carbon. 1990. Ceftriaxone-sulbactam Lombination in rabbit endocarditis caused by a strain of Klebstella pneumoniae producing extended-broad-spectrum TEM-3 β-lactamase. Antimicrob Agents Chemother. 34:21170-2074.
4. Catherall, E. J., V. Gillon, S. Hum, R. Irwin, and L. Mizen. 1992. Efficacy of ticarcillin-clavulanic acid for treatment of experimental Staphylococcus aureus endocarditis in rats. Antimicrob. Agents Chemother. 36:458-462.
5. Chambers, H. F. 1995. In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a. Antimicrob. Agents Chemother. 39:462-466
6. Chambers, H. F., M. Kartalija, and M. Sande. 1995. Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits. J. Infect Dis. 171:897-902.
7. Chambers, H. F., and M. Sachdeva. 1990. Binding of β-lactam antibiotics to penicillin-binding proteins in methicillin-resistant Staphylococcus aureus. J. Infect Dis 161:1170-1176
8. Chambers, H. F., M. Sachdeva, and S. Kennedy. 1990. Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of β-lactam antibiotics against methicillin-resistant Staphylococcus aureus. J. Infect. Dis 162:705-710.
9. De Lancastre, H., B. L. M. de Jonge, P. R. Matthews, and A. Tomasz. 1994. Molecular aspects of methicillin resistance in Staphylococcus aureus. J Antimicrob. Chemother. 33:7-24.
10. Drugeon, H. B., and R. Bismuth. 1993. Activité des inhibiteurs de bêtalactamases sur les staphylocoques: activité in vitro, p. 61-75. In Concepts actuels en antibiothérapie: les inhibiteurs de bêta-lactamases, Arnette, Paris.
11. Eliopoulos, G. M., and R. C. Moellering, Jr. 1991. Antimicrobial combinations, p. 432-492. In V. Lorian (ed ), Antibiotics in laboratory medicine. 3rd ed. The Williams & Wilkins Co., Baltimore
12. Fantin, B., and C. Carbon. 1992. In vivo antibiotic synergism: contribution of animal models. Antimicrob. Agents Chemother. 36:907-912.
13. Fantin, B., R. Leclercq, J. Duval, and C. Carbon. 1993. Fusidic acid alone or in combination with vancomycin for therapy of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 37:2466-2469.
14. Franciolli, M., J. Bille, M. P. Glauser, and P. Moreillon. 1991. β-Lactam resistance mechanisms of niethicillin-resistant Staphylococcus aureus J. Infect. Dis. 163:514-523.
15. Gomeni, R. 1983. An interactive program for individual and population parameter estimation, p. 1022-1025. In M. J. Von Bommek, N. Ball, and N. Wigertz (ed.), Medinfo 83. Elsevier/North-Holland, Amsterdam.
16. Hartman, B. J., and A. Tomasz. 1986. Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus. Antimicrob. Agents Chemother 29:85-92
17. Hirano, L., and A. S. Bayer. 1991. β-Lactam-β-lactamase-inhibitor combinations are active in experimental endocarditis caused by β-lactamase-producing oxacillin-resistant staphylococci Antimicrob. Agents Chemother. 35: 685-690.
18. Kobayashi, S., S. Arai, S. Hayashi, and T. Sakaguchi. 1989 In vitro effects of β-lactams combined with β-lactamase inhibitors against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 33:331-335.
19. Kucers, A., and N. M. Bennett. 1987. Sulbactam, p 287-294. In The use of antibiotics, 4th ed. William Heidemann Medical Books, London.
20. Mapple, P. A. C., J. M. T. Hamilton-Miller, and W. Brumfitt. 1989. Worldwide antibiotic resistance in methicillm-resistant Staphylococcus aureus. Lancet i:537-539
21. Moellering, R. C. 1993. Meeting the challenges of β-lactamases. J. Antimicrob. Chemother 31(Suppl. A): 1-8.
22. Moreillon, P. 1995. Amoxicillin-clavulanate versus methicillin or isoxazolyl penicillins for treatment of Staphylococcus aureus infections J Antimicrob. Chemother. 35:435-441
23. Noble, W. C., Z. Virani, and R. G. A. Cree. 1992. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol. Lett. 93:195-198.
24. Pearson, R. D., R. T. Steigbigel, H. T. Davis, and S. W. Chapman. 1980 Method for reliable determination of minimal lethal antibiotic concentrations. Antimicrob. Agents Chemother. 18:699-708.
25. Reynolds, P. E., and D. F. J. Brown. 1985 Penicillin-binding proteins of β-lactam-resistant strains of Staphylococcus aureus. FEBS Lett. 192:28-32.
26. Sanyal, D., A. P. Johnson, R. C. George, B. D. Cookson, and A. J. Williams. 1991 Peritonitis due to vancomycin-resistant Staphylococcus epidermidis. Lancet 337:54.
27. Steel, R. G. D., and J. H. Tovrie. 1980. Multiple comparisons, p. 172-194 In Principles and procedures of statistics: a biometrical approach. McGraw-Hill, New York.
28. Stratton, C. W., and R. C. Cooksey. 1991. Susceptibility tests: special tests, p 1153-1165 In A. Balows, W J. Hausler, Jr., K L Herrmann, H D. Isenberg, and H. J. Shadomy (ed.), Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
29. Tomasz, A., S. Nachman, and H. Leaf. 1991. Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci. Antimicrob. Agents Chemother. 35:124-129.
30. Ubukata, K., N. Yamashita, and M. Konno. 1985. Occurrence of a β-lactaminducible penicillin-binding protein in methicillin-resistant staphylococci. Antimicrob. Agents Chemother. 27:851-857.
31. Washburn, R. G., and D. T. Durack. 1981. Efficacy of ampicillin plus a β-lactamase inhibitor (CP-45,899) in experimental endocarditis due to Staphylococcus aureus. J. Infect. Dis. 144:237-243.